Lyfius Pharma’s Facility In AP Virtually Inaugurated

Hyderabad: Lyfius Pharma Pvt Ltd, a Penicillin-G manufacturer, announced the launch of its state-of-the-art Pen-G manufacturing facility, at Kakinada in Andhra Pradesh. Under the Production Linked Incentive (PLI) scheme, Lyfius Pharma has invested Rs 2,500 crore in the facility, which has an annual production capacity of 15,000 metric tonnes.

The facility was virtually inaugurated by Prime Minister Narendra Modi in the presence of Jagat Prakash Nadda, Union Minister of Chemicals; Dr Mansukh Mandaviya, Union Minister of Labour & Employment, Anupriya Patel (Union MoS Chemicals), Prataprao Jadhav (Union MoS (IC) Ayush) and Sushri Shobha Karandlaje (Union MoS Labour & Employment).

On the occasion, MV Rama Krishna, Director, Lyfius Pharma, said: “The launch of our Pen- G facility is a significant milestone in our efforts to enhance local production and reduce import dependency for critical pharmaceutical ingredients. This investment underscores our commitment to support the government’s vision of ‘Atmanirbhar Bharat’, establishing India as a global pharmaceutical manufacturing hub.” With this facility, the commercial production is set to ramp up in FY25, the Company said adding that it will boost its domestic production of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical

Ingredients (APIs).